Open AccessTherapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice
Author(s) -
R. M. M. Cleijsen,
M. E. van de Ende,
Frank P. Kroon,
Frans Verduyn Lunel,
P.P. Koopmans,
Luuk Gras,
Frank de Wolf,
David M. Burger
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm298
Subject(s) - atazanavir , ritonavir , therapeutic drug monitoring , trough concentration , medicine , protease inhibitor (pharmacology) , pharmacokinetics , pharmacology , gastroenterology , virology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy
Therapeutic drug monitoring (TDM) is being applied for a number of antiretroviral agents. Little is known about the use of TDM for atazanavir.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom